“This study will change the way we treat acute stroke,” said Dr. Dar Dowlatshahi. “With TNK, we can be faster, safer and more effective, thereby increasing the chance that our patients will recover their independence after stroke.”
The results published in The Lancet show that TNK worked as well as, if not better than, the current recommended drug, Alteplase (tPA). TNK attaches itself to the clot in the brain for a longer period of time than tPA which means that blood flow is restored faster and for a longer period of time. It is also very easy to administer, making it a game-changer when seconds count to save brain cells.
(as reported by the OHRI on June 29, 2022)
Read more here.